Literature DB >> 15085489

Liver biopsy sampling in chronic viral hepatitis.

Maria Guido1, Massimo Rugge.   

Abstract

In chronic viral hepatitis, liver biopsy is performed to grade and stage liver damage. Liver biopsy samples are usually taken with a needle using a percutaneous procedure. This method produces a core of tissue representing approximately 1/50,000th of the liver mass, which raises concern about how representative a needle biopsy can be. A critical review of the literature reveals methodological limits unacceptable in this era of evidence-based medicine. Integrating earlier experience with more recently produced data indicates that a biopsy sample 2 cm or more in length containing at least 11 complete portal tracts should be reliable for grading and staging chronic viral hepatitis.

Entities:  

Mesh:

Year:  2004        PMID: 15085489     DOI: 10.1055/s-2004-823103

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  37 in total

1.  Liver fibrosis: natural history may be affected by the biopsy sample.

Authors:  M Guido; M Rugge
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

2.  Computer-aided morphometry of liver inflammation in needle biopsies.

Authors:  N Dioguardi; B Franceschini; C Russo; F Grizzi
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

Review 4.  Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched.

Authors:  M Pinzani
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

5.  Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.

Authors:  Giada Sebastiani; Alessandro Vario; Maria Guido; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

6.  The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B.

Authors:  Rafiye Ciftciler; Seren Ozenirler; Aysegul Atak Yucel; Mustafa Cengiz; Gulbanu Erkan; Erkan Buyukdemirci; Cemile Sönmez; Guldal Yılmaz Esendaglı
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

7.  Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle.

Authors:  Thomas C Hall; Claire Deakin; Gurprit Ss Atwal; Rajeev K Singh
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 8.  Is liver biopsy still needed in children with chronic viral hepatitis?

Authors:  Maria Pokorska-Śpiewak; Barbara Kowalik-Mikołajewska; Małgorzata Aniszewska; Magdalena Pluta; Magdalena Marczyńska
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Authors:  Zachary D Goodman; Hala R Makhlouf; Lea Liu; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Patricia R Robuck; Kathleen B Schwarz
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

Review 10.  Chronic hepatitis C and liver fibrosis.

Authors:  Giada Sebastiani; Konstantinos Gkouvatsos; Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.